ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

11050	Companies
242236	Keywords
170577	Articles
130388	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 09/29/2025 at 22:05, 11 months 22 days ago

Abivax annonce l’acceptation d’un « late-breaking » abstract supplémentaire sur les essais d'induction ABTECT de phase 3, qui sera présenté à l'occasion de la semaine United European Gastroenterology
Abivax annonce l'acceptation d'un nouvel abstract sur les essais d'induction ABTECT de phase 3 pour la rectocolite hémorragique modérément à sévèrement active, à présenter à la semaine UEG

Abivax Rectocolite Hémorragique ABTECT UEG Essais D'induction
PRESS RELEASE

published on 09/29/2025 at 22:05, 11 months 22 days ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces acceptance of additional late-breaking abstract from the ABTECT Phase 3 induction trials to be presented at 2025 United European Gastroenterology (UEG) Meeting

Abivax Ulcerative Colitis Gastroenterology Late-breaking Abstract ABTECT Phase 3
BRIEF

published on 09/23/2025 at 22:10, 11 months 28 days ago

Abivax : Présentation de données prometteuses sur l'obefazimod au congrès 2025 de l'UEG

Abivax Obefazimod Rectocolite Hémorragique Phase 3 Congrès UEG
BRIEF

published on 09/23/2025 at 22:10, 11 months 28 days ago

Abivax: Presentation of promising data on obefazimod at the 2025 UEG congress

Abivax Obefazimod Ulcerative Colitis Phase 3 UEG Congress
PRESS RELEASE

published on 09/23/2025 at 22:05, 11 months 28 days ago

Abivax annonce la présentation des dernières données sur obefazimod issues des essais d'induction ABTECT de phase 3 à l'occasion du congrès 2025 de l’Union européenne de gastroentérologie
Abivax annonce la présentation des dernières données sur obefazimod lors du congrès 2025 de l’Union européenne de gastroentérologie. Analyse des essais d'induction ABTECT de phase 3. De nouveaux mécanismes dans la rectocolite hémorragique

Abivax Obefazimod Rectocolite Hémorragique Essais Cliniques UEG
PRESS RELEASE

published on 09/23/2025 at 22:05, 11 months 28 days ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting
Abivax announces presentation of late-breaking abstract for Obefazimod at 2025 United European Gastroenterology Meeting, showcasing potential as a new therapy for ulcerative colitis

Abivax Obefazimod Ulcerative Colitis Late-breaking Abstract UEG Meeting
BRIEF

published on 09/16/2025 at 18:05, 1 year ago

ABIVAX: Distribution of Share Capital and Voting Rights

Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF

published on 09/16/2025 at 18:05, 1 year ago

ABIVAX : Répartition du Capital Social et des Droits de Vote

Euronext Paris Droits De Vote Capital Social AMF Abivax
PRESS RELEASE

published on 09/16/2025 at 18:00, 1 year ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote
Communiqué réglementaire d'ABIVAX concernant le nombre d'actions et de droits de vote. Abivax développe des traitements pour les maladies inflammatoires chroniques

Droits De Vote Actions Abivax Maladies Inflammatoires Traitements
BRIEF

published on 09/16/2025 at 10:04, 1 year ago

J.P. Morgan Chase dépasse le seuil des 5% dans ABIVAX

Capital Franchissement De Seuil Actions Abivax J.P. Morgan Chase

Accesswire

Published on 09/22/2026 at 15:25, 5 minutes ago

Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 10 minutes ago

MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 15:05, 25 minutes ago

Jaguar Health Receives Fee Waivers from FDA
Published on 09/22/2026 at 14:00, 1 hour 30 minutes ago

GameSquare and Chartis Announce Strategic Data Partnership to Measure Brand and Creator Impact for User-Generated Content (UGC) Across Gaming
Published on 09/22/2026 at 14:00, 1 hour 30 minutes ago

374Water to Present New Supercritical Water Oxidation Destruction Data at WEFTEC 2026

View all ACCESSWIRE

EQS Group

Published on 09/22/2026 at 15:20, 10 minutes ago

REHLKO DOUBLES ANNUAL BACKUP POWER CAPACITY AT CHANGZHOU MANUFACTURING FACILITY
Published on 09/22/2026 at 15:10, 20 minutes ago

Ammonix Launches a New AI Architecture for High-Stakes Specialist Agents That Outperform Frontier Models at a Lower Cost
Published on 09/22/2026 at 15:10, 20 minutes ago

Hollyland Introduces LARK M3: A Flexible & Scalable Wireless Audio System for Multi-Person and Multi-Camera Production
Published on 09/22/2026 at 15:05, 25 minutes ago

More Than One-Third of Industrial Organizations See Cybersecurity Risk as a Top Obstacle to Growth, New Global Study Finds
Published on 09/22/2026 at 15:00, 30 minutes ago

Persistent’s Takeover Offer for Nagarro Successful

Les Echos

Published on 09/21/2026 at 18:19, 21 hours 11 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 21 hours 11 minutes ago

Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 21 hours 28 minutes ago

Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 21 hours 44 minutes ago

WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 21 hours 44 minutes ago

WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026

View all LES ECHOS COMFI WIRE